Invest now
Alembic Pharmaceuticals Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -825.35 -16.00 (-1.90%)Updated : 17 Jul 2026
Research on
| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Liabilities Shareholders' Equity | 8,762.59 | 7,772.94 | 6,445.58 | 6,182.83 |
| Accumulated Depreciation Total | -1,809.51 | -1,593.79 | -1,328.50 | -1,069.06 |
| Other Liabilities Total | 333.10 | 124.31 | 109.50 | 106.21 |
| Accrued Expenses | 92.73 | 84.03 | 89.18 | 74.11 |
| Long Term Debt | 121.92 | - | - | - |
| Common Stock Total | 39.31 | 39.31 | 39.31 | 39.31 |
| Other Equity Total | 38.86 | 11.83 | 15.76 | 13.51 |
| Other Current Assets Total | 50.22 | 18.13 | 20.41 | 16.64 |
| Prepaid Expenses | 80.76 | 69.18 | 50.05 | 55.32 |
| Total Assets | 8,762.59 | 7,772.94 | 6,445.58 | 6,182.83 |
| Current Portof LT Debt/ Capital Leases | 44.65 | 15.16 | 19.83 | 16.92 |
| Additional Paid- In Capital | 748.39 | 748.39 | 748.39 | 748.39 |
| Cash | 196.37 | 83.48 | 120.21 | 75.48 |
| Total Equity | 5,674.81 | 5,190.94 | 4,818.20 | 4,370.47 |
| Long Term Investments | 140.88 | 127.21 | 93.02 | 96.33 |
| Retained Earnings( Accumulated Deficit) | 4,854.32 | 4,394.46 | 4,027.26 | 3,568.69 |
| Total Common Shares Outstanding | 19.66 | 19.66 | 19.66 | 19.66 |
| Property/ Plant/ Equipment Total- Gross | 5,286.09 | 4,954.56 | 4,399.56 | 4,068.77 |
| Tangible Book Valueper Share Common Eq | 274.11 | 264.09 | 245.12 | 222.34 |
| Total Liabilities | 3,087.78 | 2,582.00 | 1,627.38 | 1,812.36 |
| Total Debt | 1,429.94 | 1,257.50 | 513.16 | 722.02 |
| Cashand Short Term Investments | 196.37 | 83.48 | 120.21 | 75.48 |
| Total Receivables Net | 1,677.75 | 1,585.68 | 1,186.06 | 1,233.81 |
| Notes Payable/ Short Term Debt | 1,218.61 | 1,195.57 | 430.45 | 635.87 |
| Accounts Receivable- Trade Net | 1,466.30 | 1,399.79 | 1,024.84 | 1,046.40 |
| Property/ Plant/ Equipment Total- Net | 3,477.29 | 3,360.76 | 3,071.07 | 2,999.73 |
| Minority Interest | -5.83 | -1.42 | - | - |
| Total Current Liabilities | 2,593.83 | 2,412.34 | 1,455.00 | 1,636.92 |
| Total Inventory | 2,567.49 | 2,331.32 | 1,701.83 | 1,528.77 |
| Accounts Payable | 835.08 | 879.89 | 735.64 | 679.81 |
| Other Currentliabilities Total | 402.76 | 237.69 | 179.90 | 230.21 |
| Total Long Term Debt | 166.68 | 46.77 | 62.88 | 69.23 |
| Intangibles Net | 286.78 | 0.00 | 0.00 | 0.00 |
| Other Long Term Assets Total | 269.62 | 166.03 | 169.63 | 123.01 |
| Note Receivable- Long Term | 15.43 | 31.15 | 33.30 | 53.74 |
| Unrealized Gain( Loss) | -6.07 | -3.05 | -12.52 | 0.57 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 4,572.59 | 4,087.79 | 3,078.56 | 2,910.02 |
| Capital Lease Obligations | 44.76 | 46.77 | 62.88 | 69.23 |
*All figures in crores except per share values
Alembic Pharmaceuticals Quick Links
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Profit Loss Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,570.50+59.15(3.91%)
389.85+12.70(3.37%)
2,268.25+66.45(3.02%)
1,933.10-16.90 (-0.87%)
2,840.00-19.55 (-0.68%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.